<DOC>
	<DOCNO>NCT02452866</DOCNO>
	<brief_summary>This Phase 3 , multi-center , prospective , open-label study evaluate safety SYM-1219 granule contain 2 gram secnidazole woman postmenarchal adolescent girl bacterial vaginosis .</brief_summary>
	<brief_title>Open-Label Study Evaluate Safety A Single Dose SYM-1219 , Granule Formulation Containing 2 Grams Secnidazole</brief_title>
	<detailed_description>Approximately 325 patient enrol . Patients determine eligible study receive SYM-1219 granule contain 2 gram secnidazole orally single dose . Patients determine eligible Baseline visit receive single dose SYM-1219 granule contain 2 gram secnidazole 4 ounce unsweetened applesauce self-administered Day 1 . Patients contact telephone Days 8 10 inquire possible adverse event . A final study visit occur Day 21 30 assess patient safety .</detailed_description>
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<mesh_term>Secnidazole</mesh_term>
	<criteria>Are adult female postmenarchal adolescent girl â‰¥ 12 year age . Are good general health confirm medical history physical examination , know medical mental health condition , Investigator 's opinion , may interfere study participation . Have negative urine pregnancy test result prior study treatment initiation . In addition , female patient childbearing potential must use acceptable form birth control determine Investigator Agree abstain alcohol 3 day follow study treatment . Have clinical diagnosis bacterial vaginosis Agree use vaginal douche similar product duration study . Are pregnant , lactating , plan become pregnant study . Are menstruate vaginal bleeding Baseline visit ( Day 1 ) . Are menopausal determine Investigator Are suspect clinically ( confirm diagnostically ) alternative cause vaginal symptom include candidiasis , Chlamydia trachomatis , Trichomonas vaginalis , Neisseria gonorrhoeae Herpes simplex Have active genital lesion , include active Herpes simplex lesion , vaginal vulvar condition could confound interpretation clinical response , determine Investigator Have consume alcohol within 12 hour prior treatment study medication . Have history abnormal Pap smear require cervical biopsy cervical cauterization within 3 month Baseline visit ( Day 1 ) . Have history cervical carcinoma carcinoma vagina vulva .</criteria>
	<gender>Female</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>